Allervie Clinical Research - Birmingham- Site Number : 8401101

Birmingham, Alabama 35209

1 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials — Enrolling by invitation